Cramer's lightning round: CRISPR Therapeutics will work perfectly in this market

Published Tue, Jan 31 20237:32 PM EST

Key Points

It's that time again! "Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.

Qualtrics International Inc: "I really like XM as a long-term growth play. ... Let these guys do their work and then it's a buy."

Clearfield Inc: "There's an analyst that cut numbers and the stock fell apart. That was ridiculous."

CRISPR Therapeutics AG: "That's one of those crazy science stocks that in this market will work perfectly."

VIDEO2:1802:18

Cramer's lightning round: CRISPR Therapeutics will work perfectly in this market

Jim Cramer's Guide to Investing

Click here to download Jim Cramer's Guide to Investing at no cost to help you build long-term wealth and invest smarter.

Sign up now for the CNBC Investing Club to follow Jim Cramer's every move in the market.

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer's world? Hit him up!
Mad Money Twitter - Jim Cramer Twitter - Facebook - Instagram

Questions, comments, suggestions for the "Mad Money" website? madcap@cnbc.com